---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-040137"
form_type: "8-K"
ticker: "CSBR"
cik: "0000771856"
company_name: "CHAMPIONS ONCOLOGY, INC."
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:31:38.645476+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Champions Oncology Q1 revenue $14.1M, net income $1.3M, adjusted EBITDA $2.0M

## Summary
- Revenue rose 12% YoY to $14.1M; net income of $1.3M vs. loss of $2.6M a year ago.
- Adjusted EBITDA of $2.0M vs. loss of $1.7M; margin improved to 49.7% from 38.8%.
- Total costs and expenses fell 15.8% to $12.7M; cash $2.9M with zero debt.
- CEO cites cost cuts and leaner operations; expects some volatility but sustained EBITDA profitability.
- Conference call scheduled for Sept. 11 at 4:30 p.m. EDT.

## SEC filing metadata
- accession: 0001628280-24-040137
- form_type: 8-K
- ticker: CSBR
- cik: 0000771856
- company_name: CHAMPIONS ONCOLOGY, INC.
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771856/000162828024040137/0001628280-24-040137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771856/000162828024040137/csbr-20240911.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-040137
- JSON: https://secwatch.observer/filing/0001628280-24-040137.json
- Plain text: https://secwatch.observer/filing/0001628280-24-040137.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.